Position in VTRS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$204,089
+$55,275 QoQ
Shares Held
12,852
+7.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#567
of 1,016 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Kathmere Capital Management, LLC holds $1,705,003 across 6 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
8,932 | $641,853 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,640 | $326,603 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
13,597 | $217,959 | |
| 4 | VTRS |
Viatris Inc
This page
|
12,852 | $204,089 | |
| 5 | HLN |
Haleon plc
|
17,050 | $159,076 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
31,526 | $155,423 |
All Filings in VTRS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $204,089 | 12,852 | Shares | Sole | 2026-07-29 | |
| 2024-12-31 | $148,814 | 11,953 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $132,830 | 11,441 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $133,916 | 12,598 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $344,719 | 28,871 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $314,828 | 29,070 | Shares | Sole | 2024-04-16 | |
| 2023-09-30 | $424,078 | 43,010 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $443,171 | 44,406 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $262,856 | 27,324 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $139,147 | 12,502 | Shares | Sole | 2023-01-24 | |
| 2020-12-31 | $1,517 | 81 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||